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Abstract
 
Because survivin-null embryos die at an early embryonic stage, the role of survivin in thymocyte
development is unknown. We have investigated the role by deleting the 
 
survivin
 
 gene only in
the T lineage and show here that loss of survivin blocks the transition from CD4
 
  
 
CD8
 
  
 
double
negative (DN) thymocytes to CD4
 
  
 
CD8
 
  
 
double positive cells. Although the pre–T cell receptor
signaling pathway is intact in survivin-deficient thymocytes, the cells cannot respond to its signals.
In response to proliferative stimuli, cycling survivin-deficient DN cells exhibit cell cycle arrest,
a spindle formation defect, and increased cell death. Strikingly, loss of survivin activates the tumor
suppressor p53. However, the developmental defects caused by survivin deficiency cannot be
rescued by p53 inactivation or introduction of Bcl-2. These lines of evidence indicate that
developing thymocytes depend on the cytoprotective function of survivin and that this function
is tightly coupled to cell proliferation but independent of p53 and Bcl-2. Thus, survivin plays a
critical role in early thymocyte development.
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Introduction
 
T lymphocyte development in thymus is a complex process
involving distinct stages of proliferation and cell death.
These stages are defined by the expression of specific cell
surface markers, commencing with CD4
 
  
 
CD8
 
  
 
double
negative (DN) cells, which proliferate and differentiate into
CD4
 
  
 
CD8
 
  
 
double positive (DP) cells. DP thymocytes
then undergo a culling process involving induced cell death
that results in populations of terminally differentiated
CD4
 
  
 
or CD8
 
  
 
single positive (SP) cells. The SP thymocytes
are released from the thymus to become mature peripheral
T cells. DN thymocytes are not only classified by their lack
of expression of CD4 and CD8, but also by their differential
expression of CD44 (Pgp-1) and CD25 (IL-2 receptor
 
  
 
chain): DN1 (CD44
 
  
 
CD25
 
 
 
), DN2 (CD44
 
  
 
CD25
 
 
 
),
DN3 (CD44
 
  
 
CD25
 
 
 
), and DN4 (CD44
 
  
 
CD25
 
 
 
; refer-
ence 1). The DN3 stage is then subdivided according to
CD44/CD25 expression or cell size: DN3E (CD44
 
 
 
CD25
 
high 
 
small) and DN3L (CD44
 
  
 
CD25
 
low 
 
large). Pro-
ductive rearrangement of the TCR
 
  
 
locus takes place during
the DN3 to DN4 transition and leads to pre-TCR expression.
Only cells expressing a functional pre-TCR undergo expo-
nential expansion, a process referred to as 
 
 
 
-selection (2–4).
Survival signals in early thymocyte progenitors are mediated
mainly by IL-7 and stem cell factor. IL-7 prevents CD25
 
 
 
pre–T cells from undergoing cell death by up-regulating
expression of the antiapoptotic gene Bcl-2 (5–7). Once a
functional pre-TCR is formed at the DN3 stage, however,
the pre-TCR takes over and provides survival signals allowing
pre–T cells to advance to the DP stage. It remains unclear
precisely which downstream signaling molecules are mobi-
lized by the pre-TCR to control survival. Bcl-2 does not
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appear to play as important a role as in the early progenitor
stage because Bcl-2 expression decreases through the
DN3L to DN4 transition (8) and is rarely detected in DN4
cells (9, 10). Several lines of evidence also suggest that a
checkpoint dependent on the tumor suppressor p53 exists
in pre–T cells to inhibit premature differentiation of thy-
mocytes before expression of the pre–TCR complex. In-
duction of p53 deficiency in CD3
 
 
 
-deficient (11), RAG-
deficient (12), or SCID mice (13–15), all of which lack a
functional pre-TCR, rescues the block in DN thymocyte
development. Therefore, it has been proposed that p53
may act as a sensor for 
 
 
 
-selection. Only thymocytes that
express a functional pre-TCR succeed in inactivating the
p53-induced cell death pathway and go on to the DP stage.
The cycling and division of almost all cell types are
tightly regulated by the controlled activation and inactiva-
tion of precise checkpoint mechanisms. Many types of cel-
lular stresses trigger p53, which in turn activates both the
G1/S and G2/M cell cycle checkpoints (16, 17). However,
damage to the mitotic spindle triggers the p53-independent
spindle checkpoint, halting the cell cycle at the metaphase-
anaphase transition (18). Cells with wild-type p53 and its
target gene p21 then undergo a form of G
 
1 
 
arrest character-
ized by resistance to antimicrotubule agents (19, 20). In
contrast, p53-deficient cells do not arrest in G
 
1 
 
and instead
endoreduplicate their DNA, resulting in cell death due to
aberrant mitosis (21, 22).
Survivin is a member of the inhibitor of apoptosis family
(23) but its direct role in apoptosis is still controversial. For
example, survivin displays no ability to suppress caspase-3
activity in vitro and does not bind procaspase-9 (24). Sur-
vivin is not highly expressed in most adult tissues, but this
protein becomes prominent in fast-growing cells such as
transformed cell lines and human cancers (23). Accord-
ingly, survivin expression is regulated in a cell cycle–
dependent fashion (25, 26). Immunohistochemical analysis
has shown that survivin associates with mitotic spindle mi-
crotubules, centromeres, and intracellular mid-bodies (27,
28). Recent studies have also shown that survivin is a chro-
mosomal passenger protein that regulates chromosome seg-
regation by interacting with other passenger proteins, such
as inner centromere protein and Aurora-B kinase (29). In-
activation of mammalian survivin or its orthologues in
lower organisms results in cytokinesis abnormalities (30–
32), particularly spindle defects (33).
Because survivin-null embryos die at an early embryonic
stage (28, 34), conventional knockout mice cannot provide
any information on the role of survivin in organogenesis.
To address whether survivin requirement is tissue specific,
we have generated conditional knockout mice in which
the 
 
survivin
 
 gene is deleted only in the T lineage. This is
also an ideal tool to investigate whether survivin directly
regulates apoptosis. We found that these animals had few
peripheral T cells or SP or DP thymocytes because thy-
mocyte development was impaired at the DN3 to DN4
transition. Mislocalization of proteins crucial for spindle
formation was evident in mutant thymocytes. Ex vivo anal-
ysis revealed that survivin-deficient thymocytes at the DN3
to DN4 transition underwent cell cycle arrest and cell
death. Although loss of survivin induced p53 and p21, nei-
ther p53 loss nor introduction of a Bcl-2 transgene could
restore the development of survivin-deficient DN3 thy-
mocytes. These results demonstrate that survivin plays an
essential role in early thymocyte development and that the
cytoprotective function of survivin cannot be replaced by
overexpression of Bcl-2 or loss of p53.
 
Materials and Methods
 
Generation of Lck-Cre;survivin
 
flox/flox 
 
Mice.
 
Three independent
overlapping genomic 
 
survivin
 
 clones were isolated from a 129/Sv
library and used to construct a targeting vector (see Fig. 1) that
was electroporated into E14K embryonic stem (ES) cells (129/
Ola). Homologous recombinants were used to generate chimeric
mice and survivin
 
flox/flox 
 
mice after the removal of the 
 
neo
 
 cassette
by transient expression of Flpe recombinase in vitro (35). Germ-
line transmission was confirmed by Southern blot analysis of tail
DNA as previously described (36). The primer sequences for ge-
nomic DNA PCR are available upon request.
 
Histological Analysis.
 
Thymi were fixed overnight at 4
 
 
 
C in
freshly prepared 4% paraformaldehyde/PBS and processed for
histology. Serial sections were stained with hematoxylin and
eosin using standard protocols.
 
Flow Cytometric Analysis and Cell Sorting.
 
Anti-CD4, CD8,
CD25, CD44, B220, CD11c, NK1.1, TCR
 
  
 
, TER-119, Mac-1,
Gr-1, and heat stable antigen (HSA) mAbs were from BD Bio-
sciences. These mAbs were directly coupled to FITC, PE, allophy-
cocyanin, or biotin. Surface marker expression by thymocytes and
peripheral T cells was analyzed using a flow cytometer (FACSCali-
bur™; Becton Dickinson) and CELLQuest™ software according
to standard protocols. Intracellular staining was performed using the
Cell Fixation/Permeabilization Kit (BD Biosciences).
Cell sorting was performed by FACS Vantage™ (Becton
Dickinson). For DN thymocytes, CD4
 
  
 
CD8
 
  
 
cells and B220
 
 
 
cells were depleted using a mixture of CD4/CD8/B220 magnetic
beads (Dynal). After two rounds of depletion, the cells were pre-
incubated with Fc-Block (BD Biosciences) and stained with
mAbs. DN3E cells were taken as HSA
 
 
 
, lineage marker (Lin)
 
 
 
(CD4, CD8, B220, CD11c, NK1.1, TCR
 
  
 
, TER-119, Mac-1,
Gr-1), and small in size. DN3L cells were HSA
 
 
 
, Lin
 
 
 
, and large
in size. DN2 cells were Lin
 
  
 
CD25
 
  
 
CD44
 
 
 
, whereas DN4 cells
were Lin
 
  
 
CD25
 
  
 
CD44
 
 
 
.
 
Cell Cycle Analysis.
 
Cell cycle analysis of thymocytes was
performed using the BrdU Flow Kit (BD Biosciences) as previ-
ously described (37). Mice were intraperitoneally injected with 1
mg BrdU (Sigma-Aldrich) 2 h before sample preparation. Cells
were prepared, stained with cell surface markers followed by anti-
BrdU Abs and 7-amino actinomycin D (7AAD; BD Biosciences),
and analyzed by flow cytometry. At least 3,000 cells of each DN
population were collected.
 
Western Blot Analysis.
 
DN thymocytes were stimulated with
anti–CD3
 
 
 
-biotin (BD Biosciences) and avidin (Sigma-Aldrich)
as previously described (38). Protein lysates were subjected to
Western blotting using Abs against phospho–extracellular signal–
regulated kinase (ERK)1/2, ERK1/2 (both from New England
Biolabs, Inc.), or actin (Sigma-Aldrich) according to standard
protocols. Anti-p53 (CM5; Novocastra; reference 39) and anti-
survivin Ab (27) were used as previously described. 
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RT-PCR Analysis.
 
Total RNA was extracted from thymo-
cytes using TRIzol (Life Technologies). cDNA was generated
with the SuperScript First-Strand Synthesis System (Invitrogen).
The primer sequences for RT-PCR are available upon request.
 
Immunofluorescence Microscopy.
 
Cells were fixed in cold metha-
nol or in freshly prepared 4% paraformaldehyde/PBS and perme-
abilized in 0.2% Triton X-100/PBS. Alternatively, cells were pre-
extracted with 0.2% Triton X-100 in PHEM buffer (80 mM Pipes,
20 mM Hepes, 1 mM EGTA, and 2 mM MgCl
 
2
 
, pH 6.8). Samples
were simultaneously fixed and extracted with 0.5% Triton X-100,
3.7% formalin, and 0.25% glutaraldehyde in PHEM buffer. Slides
were blocked in 0.5% BSA/0.02% glycine/PBS and labeled with
primary and secondary antibodies. Hoechst 33258 (Molecular
Probes) was used to stain DNA. Images were obtained using an
Olympus 1X-70 inverted microscope and Deltavision Deconvolu-
tion Microscopy software (Applied Precision). The following primary
antibodies were used: mouse anti–bovine 
 
 
 
-tubulin (Molecular
Probes), mouse–anti IAK/Aurora-A kinase and mouse anti–AIM/
Aurora-B kinase (Transduction), rabbit anti–pericentrin (Covance),
and mouse anti–phospho-histone H3 (Upstate Biotechnology).
The following secondary antibodies were used: Oregon green 488
goat anti–rabbit IgG, Oregon green 488 goat anti–mouse IgG, Al-
exa Fluor 594 goat anti–mouse IgG, and Texas red goat anti–rabbit
IgG (Molecular Probes).
 
Apoptosis Assays.
 
Evaluation of thymocyte apoptosis in vitro
was performed using the Apoptosis Detection Kit (R&D Sys-
tems) as previously described (36).
 
Results
 
Generation of Thymocyte-specific Survivin-deficient Mice.
 
We constructed a 
 
survivin
 
-targeting vector in which the 
 
neo
 
cassette was flanked by FRT sequences and 
 
survivin
 
 exon 2
was flanked by loxP sequences (Fig. 1 A). Therefore, Cre-
mediated removal of exon 2 resulted in an early frameshift
and translation termination. The conditional targeting vec-
tor was used to generate two independent ES cell lines car-
rying a floxed 
 
survivin
 
 exon 2 and a flrted 
 
neo
 
 gene (Fig. 1
B). Transient transfection of these clones with Flpe recom-
binase (35, 40) resulted in successful recombination that re-
moved 
 
neo
 
 (Fig. 1 B). Recombined ES clones were used
for blastocyst injection followed by standard breeding steps
to produce animals homozygous for the floxed survivin al-
lele (survivin
 
flox/flox 
 
mice). Survivin
 
flox/flox 
 
mice were born at
the expected Mendelian ratio and displayed no abnormali-
ties (not depicted), indicating that genetic manipulation of
the 
 
survivin
 
 gene did not interfere with survivin function.
Survivin
 
flox/flox 
 
mice were crossed with Lck-Cre transgenic
mice (41) to generate thymocyte-specific survivin-deficient
mice (Lck-survivin
 
flox/flox
 
). The lack of survivin protein in
DN thymocytes was demonstrated by Western blot analysis
of survivin protein levels (Fig. 1 C). In addition, genomic
DNA prepared from sorted DN cells was analyzed by PCR
for the detection of the floxed or deleted (
 
 
 
floxed) survivin
Figure 1. Tissue-specific targeted disruption of the
survivin locus. (A) A portion of the murine wild-type
survivin locus (top) showing exons 1–3 (open boxes)
and a 10-kb XbaI fragment. The targeting vector was
designed to generate floxed exon2 (loxP; triangles),
flank the PGK-neo cassette with FRT sequences
(ovals), and introduce a new XbaI site (X). The targeted
allele contains a diagnostic 7.0-kb XbaI fragment. To
generate the conditional allele, the neo cassette was re-
moved by transient expression of Flpe recombinase.
Cre-mediated recombination resulted in the deleted
allele. The positions of the 5  flanking probe (A) and neo
probe (B) used for genotyping are indicated. (B) Southern
blot analyses to identify survivinflox/  ES cells containing
neo (left), ES cells with neo removed (middle), and
F2 pups (right). Genomic DNA was digested with
XbaI and hybridized with probe A or B. (C) Western
blot of survivin protein in Lck-survivinflox/   and
Lck-survivinflox/flox  DN thymocytes. Wild-type sur-
vivin protein (arrowhead) and a nonspecific band (asterisk)
are indicated. Actin, loading control. (D) Detection of
deleted survivin allele in DN thymocyte subpopula-
tions. The floxed (flox) and deleted ( flox) survivin
alleles were amplified by PCR using primers a and b
shown in A. Genomic DNA samples were prepared
from the indicated DN subsets. 
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allele. The floxed allele was deleted in the majority of DN2
and DN3E cells and almost all DN3L and DN4 cells in the
mutants (Fig. 1 D).
 
Defects in Thymocyte Development in Lck-survivin
 
flox/flox
 
Mice.
 
We first compared the level of survivin expression
in DN subpopulations in mutant and control mice. RT-
PCR analysis showed that survivin mRNA was maximally
expressed at the DN3L stage in control cells (Fig. 2 A).
Flow cytometric analysis demonstrated that compared with
Lck-survivin
 
 
 
/
 
  
 
cells, intracellular survivin expression was
decreased in Lck-survivin
 
flox/flox 
 
cells starting at the DN2
stage (Fig. 2 B). This time frame is consistent with Lck
proximal promoter activity (42).
Next, we determined numbers of peripheral T cells and
thymocyte subpopulation proportions in Lck-survivin
 
flox/
 
 
 
and Lck-survivin
 
flox/flox 
 
mice at 6–8 wk of age. Flow cyto-
metric analysis revealed that the number of peripheral
TCR
 
  
 
  
 
cells was dramatically reduced in Lck-survi-
vin
 
flox/flox 
 
mice (Fig. 2 C, top). The average number of
thymocytes recovered from Lck-survivin
 
flox/flox 
 
mice was
2.41 
 
  
 
0.5 
 
  106 (n   6),  2.0% of the number of thy-
mocytes in Lck-survivin /  mice (1.22   0.6   108; n  
6). Moreover,  95% of Lck-survivinflox/flox thymocytes were
DN cells (Fig. 2 C, middle), suggesting that the loss of sur-
vivin affected either the DN to DP transition or the pro-
duction of DN cells. To distinguish between these possibil-
ities, we stained DN cells from control and mutant mice with
the early developmental markers CD25 and CD44 (Fig. 2
C, bottom). DN3 (CD25  CD44 ) cells represented  80%
of Lck-survivinflox/flox DN cells compared with  50% of
DN cells in Lck-survivin /  or Lck-survivinflox/  mice.
DN4 (CD25  CD44 ) cells were reduced to 4% in Lck-
survivinflox/flox mice compared with 30 and 34% in Lck-
survivin /  and Lck-survivinflox/flox mice, respectively.
Histological findings confirmed the block in the DN3 to
DN4 transition in the absence of survivin. Thymi in Lck-
Figure 2. Flow cytometric and histological
analyses of peripheral T cells and thymi of Lck-
Cre;survivinflox/flox mice. (A) Survivin mRNA
expression in DN cells. Levels of survivin
mRNA were analyzed in the indicated DN
subsets by RT-PCR. RNA was prepared from
DN cells sorted from wild-type thymocytes.
(B) Survivin protein expression in DN cells.
Surface staining of Lck-survivin /  (thick line)
and Lck-survivinflox/flox (dotted line) thymocytes
with anti-CD25, anti-CD44, and anti-Lin Abs
was followed by intracellular staining with anti-
survivin Ab. Lin  cells in the indicated thy-
mocyte subpopulations were electrically gated
out. (C) Impaired development of survivin-
deficient peripheral T cells and DP thymocytes.
Peripheral blood cells from Lck-survivin / ,
Lck-survivinflox/ , and Lck-survivinflox/flox mice
were stained with anti-TCR   and anti-B220
(top). Thymocytes were stained with anti-CD4
and anti-CD8 (middle), or anti-CD25 and
anti-CD44 (bottom), and the Lin  population
was examined. (D) Reduced size and cellularity
of the thymus in Lck-survivinflox/flox  mice.
Hematoxylin and eosin staining of transverse
sections of thymus from Lck-survivinflox/  (left)
and Lck-survivinflox/flox (right) mice. The mutant
thymus is much smaller and lacks the typical
cortex medulla structure.Okada et al. 403
survivinflox/  mice had a typical structure and contained a
cortex (Fig. 2 D, left, dark purple area) with immature T
cells and a medulla (Fig. 2 D, left, light purple area) with
smaller DP cells. In contrast, thymi of Lck-survivinflox/flox
mice were much smaller and lacked cortex medulla com-
partmentalization (Fig. 2 D, right). The vast majority of
thymic cells in the mutants were large and stained light
purple, which are characteristics of immature thymocytes.
These results indicate that in the absence of survivin, DN
thymocytes fail to expand and progress to the DP stage.
Normal TCR  Gene Rearrangement and In Vitro Pre-TCR
Signaling in Survivinflox/flox DN Thymocytes. The accumula-
tion of DN3 thymocytes in Lck-survivinflox/flox mice was
strikingly similar to that in RAG-1 (43), RAG-2 (44),
TCR  (45), and Lck (46) knockout mice. Therefore, we
analyzed the rearrangement of the TCR  locus, a require-
ment for the DN3 to DN4 transition. Analysis of DN thy-
mocyte DNA by PCR and Southern blotting showed that
somatic recombination of D 2-J 2 gene segments was not
altered in survivin-deficient thymocytes (Fig. 3 A). Fur-
thermore, flow cytometry revealed no differences in intra-
cellular TCR  protein between DN3E and DN3L cells of
control and mutant mice (Fig. 3 B).
The pre-TCR signaling pathway necessary for the DN3
to DN4 transition can be activated in vitro by ligating
CD3  on the surface of DN cells (47). This activation can
be assessed by determining the extent of phosphorylation
of the ERKs, downstream targets of pre-TCR signaling
(38). DN thymocytes from Lck-survivinflox/flox and Lck-
survivinflox/  mice were activated using anti-CD3  Ab fol-
lowed by detection of ERK activation via anti–phospho-
ERK Abs. As shown in Fig. 3 C, ERK1 and ERK2 were
phosphorylated equally and with comparable kinetics in
control and mutant DN cells. Intraperitoneal injection of
anti-CD3  Ab can mimic pre-TCR signaling in vivo and
induce DN cells to proliferate and differentiate into DP
Figure 3. Normal TCR  gene rearrangement and
pre-TCR signaling in Lck-Cre;survivinflox/flox  thy-
mocytes. (A) Normal TCR   D-J rearrangement.
TCR  D 2-J 2 recombination in Lck-survivinflox/ 
and Lck-survivinflox/flox DN thymocytes was examined
by PCR followed by Southern blotting with 32P-labeled
oligonucleotide probes as previously described (reference
59). The Cre gene was amplified as an internal control
for PCR. (B) Normal TCR   protein expression.
DN3E and DNL3 thymocytes from Lck-survivinflox/ 
and Lck-survivinflox/flox mice were surface stained with
anti-CD25, anti-CD44, and anti-Lin followed by intra-
cellular staining with TCR  and flow cytometric analy-
sis. (C) Normal MAPK activation. Lck-survivinflox/ 
and Lck-survivinflox/flox DN thymocytes were treated
with anti–CD3 -biotin followed by cross-linking with
avidin for the indicated times. Protein lysates were sub-
jected to Western blot analysis using anti–phospho-
ERK Abs (top). To control for loading, the blot was
stripped and reprobed with anti–ERK Ab (bottom).
(D) Impaired in vivo response of survivin-deficient
thymocytes to anti-CD3 . RAG-2 /  (left) and Lck-
survivinflox/flox (right) mice were intraperitoneally in-
jected with 100 mg anti-CD3 . After 72 h, thymocytes
were prepared and stained with anti-CD25, anti-CD44,
and anti-Lin Abs, and then subjected to flow cytometry.
Unlike RAG-2 /  DN3 cells, Lck-survivinflox/flox DN3
cells failed to advance to DN4. Data shown are repre-
sentative of three independent experiments.Loss of Survivin in Double Negative Thymocytes 404
cells in RAG-2 /  mice in the absence of pre-TCR sig-
naling (48). Therefore, we treated Lck-survivinflox/flox and
RAG-2 /  mice with anti-CD3  Ab and isolated DN thy-
mocytes 72 h after injection. Although anti-CD3  Ab in-
duced the differentiation and proliferation of DN3 cells in
RAG-2 /  mice, it failed to do so in Lck-survivinflox/flox
mice (Fig. 3 D). These results indicate that the loss of sur-
vivin does not affect TCR  rearrangement, intracellular
TCR  expression, or the pre-TCR signaling pathway it-
self. However, the DN3 to DN4 transition cannot be res-
cued by a surrogate pre-TCR signal in the absence of sur-
vivin, suggesting that survivin plays a critical role in highly
proliferative cells.
Impaired Proliferation and Increased Cell Death of Lck-sur-
vivinflox/flox DN Thymocytes. Because the pre-TCR signal-
ing required for DN cell proliferation was normal in Lck-
survivinflox/flox thymocytes, we investigated whether the loss
of DN4 cells in the mutant mice was due to impaired pro-
liferation or increased apoptosis or both. Annexin V stain-
ing for cell viability in vivo showed that 37% of DN3L and
32% of DN4 cells were annexin  in Lck-survivinflox/flox
mice (Fig. 4 A). In contrast, only 5–7% cells were annexin 
in control mice, indicating that loss of survivin induces
apoptosis of DN3L and DN4 thymocytes.
To test whether loss of survivin impaired cellular re-
sponses to external apoptotic stimuli, we subjected purified
DN cells from Lck-survivinflox/flox and RAG- 2 /  mice to
treatment with etoposide (Fig. 4 B, Etp), dexamethasone
(Dex),  -irradiation (IR), or staurosporine (STS). About
90% of thymocytes in both mutant strains are DN3E cells.
When apoptosis was evaluated at 16 h after treatment, no
significant differences in the numbers of apoptotic cells
were observed under any conditions tested (Fig. 4 B).
These results indicate that survivin is not essential in DN3E
cells for the execution of apoptosis in response to various
external stimuli in vitro. However, a failure in survivin
function triggers the death of proliferating cells in vivo.
To examine the effect of survivin loss on the cell cycle,
DN thymocytes were pulse labeled in vivo with BrdU and
stained with anti-BrdU Ab and 7AAD in vitro (Fig. 4 C).
The cell cycle profile of DN3E cells was comparable in
Lck-survivin /   and Lck-survivinflox/flox  mice (Lck-sur-
vivin / : G1, 77.1%; S, 21.0%; G2/M, 0.3% vs. Lck-sur-
vivinflox/flox: G1, 77.6%; S, 20.2%; G2/M, 0.6%). However,
Figure 4. Effect of survivin loss on cell death in vivo
and in vitro and on thymocyte proliferation. (A) Increased
cell death of proliferating survivin-deficient DN cells. DN
thymocytes were prepared ex vivo and stained with anti-
CD25, anti-CD44, and anti-Lin Ab followed by annexin.
The average number of annexin  cells in each DN sub-
population was assessed by flow cytometry. Results shown
are mean   SD. Annexin  cells were significantly increased
in Lck-survivinflox/flox  DN3L and DN4 populations
(ANOVA; n   3). (B) Normal susceptibility of resting
survivin-deficient DN cells to various apoptotic stimuli.
Lck-survivinflox/flox and RAG-2 /  DN3E cells were treated
with etoposide (Etp), dexamethasone (Dex),  -irradiation
(IR), and staurosporine (STS) at the indicated doses. Cell
death was evaluated as described in Materials and Methods.
Cell viability was normalized to account for spontaneous
cell death. Triplicate samples of each treatment in three
independent experiments were assayed. Results shown are
mean   SD. (C) Impaired proliferation in vivo in the
absence of survivin. Lck-survivinflox/  and Lck-survivinflox/flox
mice were injected with 1 mg BrdU and DN thymocytes
were purified and stained with anti-CD25, anti-CD44,
anti-BrdU, and 7AAD. The percentages of cells in the G1,
S, and G2/M phases were measured by flow cytometry for
the indicated DN subsets. Results shown are representative
of three independent experiments.Okada et al. 405
in Lck-survivinflox/flox DN3L cells, the G1 population was
increased to 33.3% (Lck-survivin / : 14.8%) and the S
population was decreased to 63% (Lck-survivin / : 80%).
In Lck-survivinflox/flox DN4 cells, the G1 population was in-
creased still further to 67.4% (Lck-survivin / : 43.7%),
whereas the S population dropped to 19.6% (Lck-
survivin / : 53.0%). In addition, sub-G1 cells represented
3.0% of DN4 thymocytes in Lck-survivinflox/flox mice but
only 0.1% of control DN4 cells. Thus, survivin is required
for the proliferation and survival of DN3L and DN4 thy-
mocytes, and a lack of survivin leads to cell cycle arrest and
cell death at these stages.
Defects in Cytokinesis in Lck-survivinflox/flox DN Thymocytes.
Embryos of mice with a null mutation of the survivin gene
show a cytokinesis defect and die early during embryogen-
esis (28, 34, and unpublished data). Overexpression of
dominant negative survivin or antisense inactivation of sur-
vivin also lead to cytokinetic defects (25, 27) and anti-sur-
vivin Ab injection results in spindle defects (49). We ex-
amined spindle formation in DN3L and DN4 cells from
Lck-survivinflox/flox and Lck-survivin /  mice by staining
thymocytes with  -tubulin. Lck-survivin /  (and Lck-sur-
vivinflox/ ) cells had well-organized and symmetrical spin-
dles (Fig. 5 A, a), whereas Lck-survivinflox/flox cells showed
shorter and thicker spindles (Fig. 5 A, b). The number of
spindle fibers was reduced in many cases, suggesting a de-
fect in the assembly of spindle microtubules. Significantly,
we found that microtubule assembly defects were en-
hanced in mitotic mutant cells compared with interphase
mutant cells (Fig. 5 B). Thus, the organization and assem-
bly of mitotic spindles is severely impaired in the absence
of survivin.
Because the intracellular localization of lpl1/Aurora ki-
nase in Caenorhabditis elegans is affected by the loss of the
survivin orthologue bir-1 (32), we examined the localization
of murine Aurora-B kinase (Aurora-B) at each mitotic
stage in DN cells of control and survivin-deficient mice. In
wild-type cells, Aurora-B localized at the centromeres until
metaphase (Fig. 5 C, b), transferred to the central spindle
during anaphase (Fig. 5 C, c), and finally accumulated at
the spindle midbody during telophase and cytokinesis (Fig.
5 C, d). However, in survivin-deficient cells, Aurora-B
could not localize at either the midzone or midbody at ei-
ther anaphase or telophase (Fig. 5 C, e–h). Indeed, no typ-
ical telophase cells could be found among survivin-defi-
cient DN thymocytes.
p53 Induction in Lck-survivinflox/flox DN Thymocytes. In-
creased cell death and cell cycle arrest are hallmarks of p53
Figure 5. Defects in cytokinesis of Lck-
survivinflox/flox DN thymocytes. (A) Impaired
spindle formation. Purified DN3L and DN4 cells
from Lck-survivin /  (a) and Lck-survivinflox/flox
(b) mice were stained with anti– -tubulin
(green). DNA was visualized with Hoechst
33258 (blue) staining. Data shown are represen-
tative of at least three independent preparations
per genotype. (B) Severe impairment of spindle
assembly in mitotic cells. Spindle assembly in
cells from Lck-survivinflox/flox mice was compared
at interphase (bottom left) and mitosis (top
right). Cells were stained with anti– -tubulin
(green), anti–phospho-histone H3 (p-H3) Ab
(red), and Hoechst (blue). a,  -tubulin; b, anti–
p-H3 and Hoechst; c, merge. (C) Impaired
cytokinesis and localization of Aurora-B kinase.
Mitotic DN3L and DN4 cells from Lck-
survivin /  (a–d) and Lck-survivinflox/flox (e–h)
mice were stained with anti–p-H3 Ab (red),
anti–Aurora-B kinase Ab (green), and Hoechst
(blue). a and e, prometaphase; b and f, meta-
phase; c and g, anaphase; d and h, telophase/
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function. To test whether loss of survivin induced p53, we
investigated the status of p53 protein in Lck-survivinflox/flox
DN cells. We found that p53 protein expression was in-
deed induced in Lck-survivinflox/flox DN cells but not in
Lck-survivinflox/  DN cells (Fig. 6 A, top). Flow cytometric
analysis of intracellular p53 protein confirmed that p53 was
expressed in survivin-deficient DN2 to DN4 cells (Fig. 6
B). In addition, RT-PCR analysis showed that expression
of the p53 target gene p21 was induced in Lck-survi-
vinlox/lox DN cells (Fig. 6 A, bottom). These results sug-
gested that p53 might be responsible for the increased
apoptosis and arrest observed in Lck-survivinflox/flox mice.
Gain of Bcl-2 or Loss of p53 Expression Does Not Rescue
DN Thymocyte Developmental Defects Induced by Survivin
Loss. We determined whether Bcl-2 could rescue sur-
vivin deficiency by crossing Lck-survivinflox/flox  mice to
E -Bcl-2 transgenic mice to generate Lck-survivinflox/flox;
Bcl-2 animals. The total number of thymocytes in Lck-sur-
vivinflox/flox;Bcl-2 mice (2.2   0.7   106; n   4) was com-
parable to that in Lck-survivinflox/flox mice (2.4   0.5  
106; n   4; Fig. 7 A). The number of DN cells was also un-
altered in the presence of the Bcl-2 transgene (Lck-sur-
vivinflox/flox vs. Lck-survivinflox/flox;Bcl-2; 2.3   0.5   106
vs. 2.1   0.6   106; n   4), suggesting that Bcl-2 overex-
pression cannot overcome cell death induced by an absence
of survivin.
To test whether survivin deficiency had a direct impact
on p53-mediated apoptosis, we generated compound con-
ditional survivin mutants by crossing Lck-survivinflox/flox
mice to p53 /  mice to generate Lck-survivinflox/flox;p53 / 
animals. In mice lacking both survivin and p53, the total
number of thymocytes was decreased (0.33   0.106; n   3)
compared with Lck-survivinflox/flox;p53 /  controls (1.23  
0.12   106; n   3). The percentage of DN thymocytes in
the double mutants was decreased by 10% at most (n   3),
whereas the percentages of DP and SP thymocytes were
slightly (not significantly) increased (Fig. 7 B), indicating
that loss of p53 cannot restore DN thymocyte development
in the absence of survivin.
Loss of p53 or p21 Expression Releases Cell Cycle Arrest but
Accelerates Apoptosis Induced by Survivin Loss. Next, we ex-
amined cell cycle status and apoptosis in survivin-deficient
thymocytes also lacking either p53 or p21. In both cases,
the G1 subpopulation of DN3L thymocytes was restored to
the control level (Lck-survivinflox/  vs. Lck-survivinflox/flox
vs. Lck-survivinflox/flox;p53 /  vs. Lck-survivinflox/flox;p21 / ;
35.3 vs. 51.1 vs. 35.6 vs. 37.0%; Fig. 7 C, middle). Thus,
cell cycle arrest induced by loss of survivin is mediated by
the p53 pathway and involves p21 induction. The G1 sub-
population of DN4 thymocytes was reduced by  80% re-
gardless of genetic background, suggesting profound cell
damage resulted in these cells. These results suggest that loss
Figure 6. Induction of p53 and p21 in Lck-
survivinflox/flox DN thymocytes. (A) p53 and p21
induction in DN thymocytes. Top: Protein sam-
ples prepared from Lck-survivinflox/  and Lck-
survivinflox/flox DN cells were subjected to Western
blot analysis using anti-p53 Ab followed by reprobing
with anti-actin as a loading control. Bottom: Levels
of p21 and HPRT (loading control) mRNA in
control and mutant DN cells were determined by
RT-PCR. (B) p53 induction in DN subpopulations.
Lck-survivinflox/  and Lck-survivinflox/flox thymocytes
were surface stained with anti-CD25, anti-CD44,
and anti-Lin followed by intracellular staining with
anti-p53 or control IgG. p53 protein in each DN
subpopulation was assessed by flow cytometry.Okada et al. 407
of survivin, as well as triggering p53-mediated growth ar-
rest, precipitates aberrant mitosis that inexorably causes the
death of affected cells regardless of their p53 or p21 status.
Indeed, annexin staining showed that the viability of
DN3E and DN3L cells was significantly decreased when
both survivin and either p53 or p21 were missing (Fig. 7
D). Thus, the loss of the cytoprotective function of sur-
vivin appears to trigger p53 induction and cell cycle arrest,
but the death of survivin-deficient cells involves a mecha-
nism that is independent of p53.
Discussion
In this study, we have defined the role of survivin in thy-
mocyte development and have investigated the biochemis-
try underlying its effects. The conditional deletion of the
survivin gene in thymocytes revealed that survivin has vital
functions in both cell death and proliferation in vivo. But
we could not find any evidence that survivin directly regu-
lates apoptotic pathway.
Control of cell survival and proliferation is fundamental
to normal T cell development, and signaling via the pre-
TCR contributes to the regulation of both these processes
during early thymocyte maturation (4, 50). Whether the
pre-TCR also mediates anti-apoptosis has not been well
clarified. Is survivin required for these pre-TCR–mediated
signals? Our data show that the DN3 to DN4 transition is
severely impaired in Lck-survivinflox/flox mice. Profound re-
ductions in DP and SP cell numbers occur that lead to a
decrease in total thymic cellularity (Fig. 2, C and D). Thus,
the proliferation and survival of DN3L and DN4 cells,
which are known to depend on pre-TCR signaling, are
also dependent on survivin function. Once survivin is inac-
tivated, DN3L and DN4 cells lose their ability to expand
and eventually die. In our study, survivin was up-regulated
during the DN3E to DN3L transition (Fig. 2, A and B),
and loss of survivin led to a drastic increase in the number
of cells undergoing cell cycle arrest and cell death (Fig. 4).
This phenotype is reminiscent of that of mice missing any
component (TCR , pT , CD3 molecules) of the pre-
Figure 7. Effects of Bcl-2 gain or p53 loss on phenotypes
of survivin-deficient thymocytes. (A) Gain of Bcl-2 does
not restore DP cells in the absence of survivin. Thymocytes
prepared from Lck-survivinflox/ ;Bcl-2, Lck-survivinflox/flox,
and Lck-survivinflox/flox;Bcl-2 mice were stained with anti-
CD4 and anti-CD8 followed by flow cytometric analysis.
One experiment representative of four independent trials is
shown. (B) Loss of p53 does not rescue DN thymocyte
development in the absence of survivin. CD4/CD8 ex-
pression was determined as in A for thymocytes from Lck-
survivinflox/ ;p53 / , Lck-survivinflox/flox;p53 / , and Lck-
survivinflox/flox;p53 /  mice. (C) Decreased G1 arrest of
survivin-deficient DN3L cells in the p53 /  and p21 / 
genetic backgrounds. Cell cycle profiles of DN cells pre-
pared from Lck-survivinflox/ , Lck-survivinflox/flox, Lck-
survivinflox/flox;p53 / , and Lck-survivinflox/flox;p21 / 
mice were determined as in Fig. 4 B. (D) Increased cell
death of survivin-deficient DN cells in the p53 /  and p21
genetic backgrounds. The percentages of annexin  cells in
the indicated DN subpopulations were determined as in
Fig. 4 A. Results shown are mean   SD. Annexin  cells
were significantly increased in p53 /  and p21 /  genetic
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TCR. However, survivin-deficient DN cells retain normal
expression of rearranged TCR  and pre-TCR signaling
components (Fig. 3, A–C). Although anti-CD3 Ab can
overcome the block in RAG-2 /  DN cells, such treat-
ment does not restore survivin-deficient DN thymocyte
development (Fig. 3 D). Thus, the initiating elements of
pre-TCR signaling are intact in survivin-deficient cells but
survivin is required for the actual expansion of thymocytes
in response to pre-TCR signaling.
Although survivin is a member of inhibitor of apoptosis
family, its direct role in apoptosis is still controversial (29,
51, 52). In our system, survivin-deficient cells exhibited
normal susceptibility to various external apoptotic stimuli
in vitro (Fig. 4 B). In addition, survivin deficiency in
DN3E cells did not induce spontaneous apoptosis (Fig. 4
A). However, a failure in survivin function triggers cell
death of highly proliferating DN cells (Fig. 4 A). Based on
these findings, we conclude that survivin primarily plays a
critical role in mitosis progression but does not directly reg-
ulate apoptosis. Inactivation of survivin in proliferating cells
induces severe defects in chromosome segregation and cy-
tokinesis, and subsequent cell death with the morphology
representing mitotic catastrophe (not depicted). On the
other hand, cofactor-dependent caspase inhibition of sur-
vivin has recently been reported (24). Further analysis of
survivin’s cytoprotective functions in a tissue- or cell con-
text–specific manner is therefore necessary.
p53 has a critical role in transducing signals from dam-
aged DNA that control the cell cycle and apoptosis in
mammalian cells (16, 17). In mutant mice with impaired
pre-TCR expression, p53 deficiency can rescue the block
in DN thymocyte development (11–15). This genetic evi-
dence has suggested a model in which a p53-mediated
checkpoint operates during pre–T cell development to
sense and eliminate thymocytes that attempt to differentiate
before the formation of a functional pre-TCR complex. In
this scenario, the pre-TCR regulates the DN to DP transi-
tion by inactivating p53. However, others have suggested
that the pre-TCR checkpoint may involve a p53-indepen-
dent cell death pathway (11). In this study, we have shown
that the death of survivin-deficient DN thymocytes in-
volves such a pathway (Fig. 7) and we hypothesize that sur-
vivin controls critical aspects of the DN to DP transition.
This hypothesis is consistent with recent reports that sur-
vivin is required for the maintenance of the spindle check-
point. For example, in survivin-depleted cells, the spindle
checkpoint molecules BubR1 and Mad2 are prematurely
displaced from kinetochores and the spindle checkpoint
cannot be maintained (53, 54).
We speculate that in exponentially growing DN thy-
mocytes, survivin might be critical for maintaining the in-
tegrity of the rapidly forming spindles. Although the pre-
cise mechanism underlying the induction of p53 by spindle
damage remains unknown, defects in centrosome duplica-
tion have been suggested to activate the p53 pathway (55).
We found that survivin-deficient cells exhibited abnormal
spindle formation (Fig. 5, A and B). Thus, the loss of sur-
vivin in the mutant cells may have activated the same p53
signaling pathway as seen in cells treated with microtubule-
damaging agents (56). p53-mediated induction of p21 is re-
quired for the arrest of spindle-damaged cells at G1 (18).
We also observed that p21 was highly up-regulated in sur-
vivin-deficient cells (Fig. 6 A) and that loss of p21 released
the cell cycle arrest (Fig. 7 C). The p53 protein also has di-
rect effects on other aspects of mitosis. For example, p53
controls centrosome duplication via a p21-dependent
mechanism (57). p53 also binds directly to Aurora-A and
suppresses Aurora-A–induced centrosome amplification
(58). It is not hard to imagine that loss of survivin coupled
with p53 inactivation might have cumulative devastating
effects on mitosis.
Our work has generated useful genetic tools for the
study of survivin functions in various tissues and pathologi-
cal conditions. Further study of T cell–specific survivin-
deficient mice and additional mutants should reveal much
about pre-TCR signaling and the p53- and Bcl-2–inde-
pendent mechanisms involved in cell death induced by loss
of survivin. Research to define these pathways may shed
new light on regulatory mechanisms governing cell death
and proliferation, which could in turn ultimately lead to
novel therapeutic targets.
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